IP Library Granted Patent US 7,579,494
Granted Patent B2
US 7,579,494 · App. 11/838,012 · Granted Aug 25, 2009

Prevention of neutrophil recruitment

Assignee: The Brigham and Women's Hospital, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,579,494
App. No.
11/838,012
Granted
Aug 25, 2009
Kind
B2
Abstract

Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.

Claims (22)

1. A compound having the formula:

wherein X is R 1 , OR 1 , or SR 1 ;

wherein R 1 is

(i) a hydrogen atom;

(ii) an alkyl of 1 to 8 carbons atoms, inclusive, which may be straight chain or branched;

(iii) a cycloalkyl of 3 to 10 carbon atoms;

(iv) an aralkyl of 7 to 12 carbon atoms;

(v) phenyl;

(vi) substituted phenyl

wherein Z i , Z ii , Z iii , Z iv and Z v are each independently selected from —NO 2 , —CN, —C(═O)—R 1 , —SO 3 H, a hydrogen atom, halogen, methyl, —OR x , wherein R x is 1 to 8 carbon atoms, inclusive, which may be a straight chain or branched, and hydroxyl;

(vii) a detectable label molecule; or

(viii) a straight or branched chain alkenyl of 2 to 8 carbon atoms, inclusive;

wherein Q 1 is (C═O), SO 2 or (CN), provided when Q 1 is CN, then X is absent;

wherein R 4 is

(a) H;

(b) an alkyl of 1 to 6 carbon atoms, inclusive, which may be a straight chain or branched;

wherein R 5 is

wherein Z i , Z ii , Z iii , Z iv and Z v are each independently selected from —NO 2 , —CN, —C(═O)—R 1 , —SO 3 H, a hydrogen atom, halogen, methyl, —OR x , wherein R x is 1 to 8 carbon atoms, inclusive, which may be a straight chain or branched, and hydroxyl or a substituted or unsubstituted, branched or unbranched alkyl group;

wherein R 6 is

(a) H;

(b) an alkyl from 1 to 4 carbon atoms, inclusive, straight chain or branched;

and pharmaceutically acceptable salts thereof excluding 16-phenoxy-LXA 4 and 15-epi-16-(para-fluoro)-phenoxy-LXA 4 .

Assignments (1)
CONFIRMATORY LICENSE Recorded Apr 1, 2023
From: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 063198/0346 →
Continuity (7)
Continuation 1174289300 · May 1, 2007
Division 1110606600 · Apr 13, 2005
Continuation 1036619400 · Feb 13, 2003
Continuation 1017674400 · Jun 20, 2002
Division 0952574200 · Mar 14, 2000
Provisional Application 6012520900 · Mar 18, 1999
Related Publication 20080064747A1 · Mar 13, 2008